AGIO earnings call for the period ending June 30, 2019.
News & Analysis: Agios Pharmaceuticals
AGIO earnings call for the period ending March 31, 2019.
AGIO earnings call for the period ending December 31, 2018.
If GlaxoSmithKline's recent splurge signals a new round of acquisitions, these stocks could be next.
On a positive day for the market, these stocks outperformed. Find out why.
Short-sellers have piled on Agios, Insys, Intercept, Lexicon, and Myriad Genetics. But are they wrong?
Funding isn't a big concern for these three drug developers.
It was a roller-coaster year for investors in the clinical-stage biotech. Here's a review of the year's key headlines that caused shares to drop.
The biotech is left without a backup plan.
Flexion Therapeutics, Kite Pharma, and Agios Pharma all have drugs that could make their way to the FDA in the coming months.